EP
MYOK

Eversept Partners’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Eversept Partners’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-70,594
Closed -$6.82M – 76
2020
Q2 		$6.82M Buy
70,594
+42,842
+154% +$3.57M 0.94% 28
2020
Q1 		$1.3M Buy
27,752
+6,300
+29% +$404K 0.32% 35
2019
Q4 		$1.56M Buy
+21,452
New +$1.3M 0.28% 57
2019
Q3 		– Sell
-56,652
Closed -$2.84M – 70
2019
Q2 		$2.84M Buy
56,652
+21,600
+62% +$1.05M 0.8% 29
2019
Q1 		$1.82M Buy
+35,052
New +$1.61M 0.53% 33
2018
Q3 		– Sell
-25,950
Closed -$1.29M – 81
2018
Q2 		$1.29M Sell
25,950
-16,050
-38% -$777K 0.59% 37
2018
Q1 		$2.05M Sell
42,000
-8,000
-16% -$416K 0.95% 25
2017
Q4 		$2.1M Buy
+50,000
New +$1.93M 1.21% 22

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return